BLOOMINGTON, Ind. – The Indiana Life Sciences Collaboration Series, presented by the Center for the Business of Life Sciences at the Indiana University Kelley School of Business, addresses issues facing Indiana companies and Hoosiers in general.
Topics that will be discussed during the 2023-24 series include persistent disparities in access to health treatment, the effect of the Inflation Reduction Act on the cost of prescriptions and healthcare plans, and the expanding involvement of Big Tech firms on the industry.
Now in its 17th year, the conference series receives support from BioCrossroads, Indiana’s leading initiative to grow, advance and invest in the life sciences. Darshan Shah, executive vice president for data and AnalytiXIN at the Central Indiana Corporate Partnership and serves on the advisory council for Kelley’s Center for the Business of Life Sciences, said the conferences provide a valuable forum for discussing key issues facing the state’s life sciences industry.
“As a frequent attendee of IU’s Center for the Business of Life Sciences’ convenings, I know the value of the information shared by some of the leading minds and innovators working in the life sciences sector,” said Shah, who has regularly attended the conference series since while he was completing his MBA at Kelley School. “It’s an excellent place to learn about the challenges we face and to find your place as part of the solution.”
The Center for the Business of Life Sciences brings together key players from industry, academia, government, and economic development communities to share ideas and expertise. It drives the Kelley School’s life sciences agenda and provides connections to its outreach and research activity and its academic programs.
“BioCrossoads’ role over the years to educate people as to the industry’s size and significance to the state has gained it much respect and credibility. Having their support and involvement will help do the same for the conferences,” said George Telthorst, the center’s director. “BioCrossroads is a touchpoint for many start-ups they invest in as well as strong relationships with large long established companies in the industry.”
Telthorst said the healthcare ecosystem is so tightly interconnected that it makes sense to look at the bigger picture though the conferences, as opposed to focusing strictly on life sciences companies.
“It’s better to think of it more as a ‘value web’ and not a ‘value chain’ – things impacting one part can be felt throughout the system. Many of these issues impact all companies and communities in one way or another as payers, providers, and consumers,” he said.
“The series gives people from across the ecosystem a reason to get together and make connections they otherwise might not have made. It also provides opportunities to learn from seasoned executives and researchers and build a sense of camaraderie and synergies among professionals working in this highly regulated industry.”
Here’s the schedule for the conference series:
- Dec. 1, at Roche Diagnostics in Indianapolis – “Closing the Gap of Health Equalities.” The program will examine ongoing efforts to improve both the delivery of healthcare and health-related social factors like access to healthy foods, access to transportation and safe neighborhoods, which influence health outcomes.
- Feb 16, 2024, at Ice Miller LLP in Indianapolis – “Industry Impact of the Inflation Reduction Act.” Various stakeholders from across the industry will share their perspectives on the law’s current and future effects on healthcare plans, product portfolios and patient choices and costs.
- April 19, 2024, at the Indiana Biosciences Research Institute in 16 Tech Innovation District in Indianapolis – “Tech: Don’t Be Afraid of Healthcare!” Close observers and “those in the trenches” will provide analysis of Big Tech companies like Microsoft and Alphabet and their attempts to expand into healthcare.
The registration fee is $450 for the series or $175 for individual conference and lunch is included. Registration can be done online or by contacting Kelli Conder at the Kelley School at 812-856-0915 or email@example.com. Full-time students an at accredited Indiana institution of higher learning may qualify for a student discount. Contact Conder for more information.
Series sponsors are Commissioning Agents, Inc., Elevance Health, Lilly, LabCorp and Reckitt Benckiser. Other sponsors are Blueprint Marketing Group, Boston Scientific, Cook, Crowe, Deloitte, Fort Wayne Metals, hc1, Ice Miller, the Indiana Clinical and Transitional Sciences Institute, Miles Printing, Paragon, Purdue University, Roche and Taft Stettinius & Hollister LLP.
Marketing sponsors are the Bloomington Economic Development Corporation, Indiana Health Information Exchange, IU Office of University Relations, and Linking Pharma Women.